Biotech weighs on S&P

Now watching

Next video starts in : 7 Play

Biotech weighs on S&P

Biotech weighs on S&P
Replay video
Up next

Cramer: One IPO that proves Silicon Valley unicorns have ...

Unlock your personal NFL Now stream by signing in to NFL.com

Biotech weighs on S&P

by CNBC Videos 1:20 mins

CNBC's Dominic Chu reports the health care sector is being dragged down by the biotech sector. Congressional Democrats asked biotech company Gilead to provide insight on pricing for its hepatitis C drug Sovaldi.

View Comments (0)